Avalon Investment & Advisory Sells 2,556 Shares of Novartis AG (NYSE:NVS)

Avalon Investment & Advisory reduced its stake in Novartis AG (NYSE:NVS – Get Rating) by 5.5% in the 4th quarter, Holdings Channel reports. The firm owned 43,544 shares of the company’s stock after selling 2,556 shares during the period. Avalon Investment & Advisory’s holdings in Novartis were worth $3,950,000 as of its most recent filing […]

Related Keywords

,Wealth Advisors Inc ,Novartis ,Penserra Capital Management ,Front Row Advisors ,Novartis Pharmaceuticals ,Financial Management Professionals Inc ,Corecap Advisors ,Holdings Channel ,Deutsche Bank Aktiengesellschaft ,Avalon Investment ,Get Rating ,Management Professionals ,Capital Management ,Cap Advisors ,Row Advisors ,Innovative Medicines ,Novartis Oncology ,Visit Holdingschannel ,Novartis Daily ,Nyse Nvs ,Nvs ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,